Evidence map›Paper›PMID 30311390›Full record

ArticleHuman mutation2018

Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene.

Diane B Zastrow, Heather Baudet, Wei Shen, Amanda Thomas, Yue Si, Meredith A Weaver, Angela M Lager, Jixia Liu, Rachel Mangels, Selina S Dwight and 14 more

Abstract read
In one paragraph

Article in Human mutation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. AAVC: An automated framework for high-accuracy ACMG-based variant classification.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Spectrum ofBiomedical reports · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Diane B ZastrowPalo Alto Medical Foundation, Palo Alto, California.ORCID 0000-0002-8506-6812
Heather BaudetUniversity of North Carolina, Chapel Hill, North Carolina.
Wei ShenARUP Laboratories, Salt Lake City, Utah.ORCID 0000-0002-3779-0451
Amanda ThomasDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York.
Yue SiGeneDx, Gaithersburg, Maryland.
Meredith A WeaverAmerican College of Medical Genetics and Genomics, Bethesda, Maryland.
Angela M LagerSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
Jixia LiuMarshfield Clinic Research Institute, Marshfield, Wisconsin.
Rachel MangelsStanford University, Stanford, California.
Selina S DwightStanford University, Stanford, California.ORCID 0000-0002-8546-7798
Matt W WrightStanford University, Stanford, California.ORCID 0000-0002-2650-2426
Steven F DobrowolskiUniversity of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Karen EilbeckUniversity of Utah, Salt Lake City, Utah.ORCID 0000-0002-0831-6427
Gregory M EnnsStanford University, Stanford, California.
Annette FeigenbaumRady Children's Hospital and University of California, San Diego, California.
Uta Lichter-KoneckiChildren's Hospital of Pittsburg of UPMC, University of Pittsburgh, Pittsburgh, Pennsylvania.
Elaine LyonARUP Laboratories, Salt Lake City, Utah.
Marzia PasqualiARUP Laboratories, Salt Lake City, Utah.
Michael WatsonAmerican College of Medical Genetics and Genomics, Bethesda, Maryland.
Nenad BlauDietmar-Hopp Metabolic Center, University Children's Hospital, Department of General Pediatrics, Heidelberg, Germany.ORCID 0000-0003-4347-3230
Robert D SteinerMarshfield Clinic Research Institute, Marshfield, Wisconsin.ORCID 0000-0003-4177-4590
William J CraigenBaylor College of Medicine, Houston, Texas.
Rong MaoARUP Laboratories, Salt Lake City, Utah.
ClinGen Inborn Errors of Metabolism Working Group

Funding

Resource ProjectU41HG006834 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI REHM, HEIDI L · 2013 to 2020
$26.9M
The Future of PharmGKB Funding Under NHGRIU41HG009649 · NHGRI · STANFORD UNIVERSITY · PI BUSTAMANTE, CARLOS DANIEL · 2017 to 2020
$13.4M
The Clinical Genome Resource - Expert Curation and EHR IntegrationU41HG009650 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, GODDARD, KATRINA A. · 2017 to 2020
$13.3M
Clinically Relevant Genome Variation DatabaseU01HG007436 · NHGRI · STANFORD UNIVERSITY · PI BUSTAMANTE, CARLOS DANIEL, PLON, SHARON E. · 2013 to 2016
$10.5M
A Knowledge Base for Clinically Relevant Genes and VariantsU01HG007437 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, EVANS, JAMES PHILIP · 2013 to 2016
$9.0M
NHGRI NIH HHS U01HG007436NHGRI NIH HHS U01 HG007437NHGRI NIH HHS U41 HG006834NHGRI NIH HHS U41HG006834NHGRI NIH HHS U41 HG009649NHGRI NIH HHS U41HG009649NHGRI NIH HHS U41 HG009650NHGRI NIH HHS U41HG009650
6 · The paper itself

Abstract

The ClinGen Inborn Errors of Metabolism Working Group was tasked with creating a comprehensive, standardized knowledge base of genes and variants for metabolic diseases. Phenylalanine hydroxylase (PAH) deficiency was chosen to pilot development of the Working Group's standards and guidelines. A PAH variant curation expert panel (VCEP) was created to facilitate this process. Following ACMG-AMP variant interpretation guidelines, we present the development of these standards in the context of PAH variant curation and interpretation. Existing ACMG-AMP rules were adjusted based on disease (6) or strength (5) or both (2). Disease adjustments include allele frequency thresholds, functional assay thresholds, and phenotype-specific guidelines. Our validation of PAH-specific variant interpretation guidelines is presented using 85 variants. The PAH VCEP interpretations were concordant with existing interpretations in ClinVar for 69 variants (81%). Development of biocurator tools and standards are also described. Using the PAH-specific ACMG-AMP guidelines, 714 PAH variants have been curated and will be submitted to ClinVar. We also discuss strategies and challenges in applying ACMG-AMP guidelines to autosomal recessive metabolic disease, and the curation of variants in these genes.

Indexed as

Databases, GeneticGene FrequencyGenetic TestingGenetic VariationGenome, HumanHumansMetabolism, Inborn ErrorsPhenylalanine HydroxylasePhenylalanine HydroxylaseClinGeninborn errors of metabolismPAH deficiencyphenylalanine hydroxylasevariant interpretation

Identifiers

PMID30311390
PMCPMC6556116

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.